IceCure Medical Ltd.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Caesarea
ICCM chart
What traders are saying about $ICCM
Latest postsIceCure Medical Ltd. news
- Top 5 Healthcare and Biotech Pre-Market Gainers on Tuesday: Co-Diagnostics (NASDAQ:CODX) +29.47%, Skye Bioscience, Inc. (NASDAQ:SKYE) +15.93%, Harrow, Inc. (NASDAQ:HROW) +15.13%, Senseonics (NASDAQ:SENS) +13.27%, IceCure Medical (
Kalkine ·
- Why Has IceCure Medical (NASDAQ:ICCM) Climbed 11.87% in Pre-Market Trade on Tuesday?
Kalkine ·
- IceCure Medical Secures New Chinese Patent for Cryogenic Technology Connector
investorshub.advfn.com ·
- IceCure Medical Granted New Patent in China for Cryogenic Connector
TipRanks ·
- China grants a patent for a component of IceCure Medical (ICCM)'s tumor-freezing technology.
Stock Titan ·
- IceCure Medical receives China patent for cryogenic system connector
StreetInsider ·
- IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP Portfolio
Yahoo Finance ·
- Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
Yahoo Finance ·
- IceCure enrols initial patients for ProSense cryoablation trial in US
medicaldevice-network.com ·
- IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
Yahoo Finance ·
- IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Yahoo Finance ·
IceCure Medical Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.4M | $3.3M | $3.2M | $3.1M |
| Net income | -$15.1M | -$15.3M | -$14.7M | -$17.0M |
| Diluted EPS | $0.24 | $0.30 | $0.32 | $0.46 |
| Total assets (year end) | $13.9M | $12.6M | $16.4M | $30.2M |
| Cash and equivalents (year end) | $8.9M | $7.6M | $10.5M | $23.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About IceCure Medical Ltd.
- Ticker
- ICCM (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Caesarea
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1584371
Frequently asked questions
What exchange is IceCure Medical Ltd. listed on?
IceCure Medical Ltd. trades on the Nasdaq under the ticker symbol ICCM.
What industry is IceCure Medical Ltd. in?
IceCure Medical Ltd. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is IceCure Medical Ltd. headquartered?
IceCure Medical Ltd.'s business address on file with the SEC is in Caesarea.
When does IceCure Medical Ltd.'s fiscal year end?
IceCure Medical Ltd.'s fiscal year ends on December 31.
How much revenue did IceCure Medical Ltd. report?
IceCure Medical Ltd. reported $3.4M in revenue for calendar year 2025, according to its SEC filings.